REGIONAL AND SYSTEMIC SERUM CONCENTRATIONS OF 5-FLUOROURACIL AFTER PORTAL AND INTRAVENOUS-INFUSION - EXPERIMENTAL-STUDY IN DOGS

被引:20
作者
GUSTAVSSON, BG [1 ]
BRANDBERG, A [1 ]
REGARDH, CG [1 ]
ALMERSJO, OE [1 ]
机构
[1] GOTHENBURG UNIV,INST MED MICROBIOL,S-41345 GOTHENBURG,SWEDEN
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1979年 / 7卷 / 06期
关键词
5-fluorouracil; 5-FU; constant regional infusion; liver metabolism;
D O I
10.1007/BF01061213
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serum and urinary concentrations of 5-FU after continuous portal and jugular infusion have been followed by means of a highly sensitive microbiological assay method. Our data indicate that more than 90% of 5-FU was eliminated in the liver after continuous portal infusion of 0.625 mg × kg-1× hr-1, corresponding to a dose of 15 mg × kg-1 ×24 hr-1. Negligible amounts of intact 5-FU were excreted into the bile, and the urinary excretion was only a few percent of the amount infused. The arterial concentration was on average tenfold higher during the continuous jugular infusion than after the continuous portal infusion, indicating that the route of administration has a pronounced effect on the disposition of 5-FU. Twenty-three percent of the jugular dose reached the liver; 77% was degraded by extrahepatic metabolism. Of these, degradation in the prehepatic splanchnic area accounted for 15%. © 1979 Plenum Publishing Corporation.
引用
收藏
页码:665 / 673
页数:9
相关论文
共 29 条
  • [1] ALMERSJO O, 1976, European Surgical Research, V8, P489, DOI 10.1159/000127895
  • [2] ALMERSJO O, 1976, ANN CHIR GYNAECOL FE, V65, P27
  • [3] ALMERSJO O, 1977, ACTA PATHOL MICROBIO, V85, P227
  • [4] ALMERSJO O, UNPUBLISHED
  • [5] AMBRE JJ, 1971, J LAB CLIN MED, V78, P343
  • [6] RELATIONSHIP BETWEEN HEMATOCRIT AND SOLUBILITY OF 133XE IN BLOOD
    ANDERSEN, AM
    LADEFOGED, J
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (11) : 1684 - +
  • [7] DECREASE OF OXYGEN-CONSUMPTION IN DOG LIVER DURING TEMPORARY ARTERIAL-OCCLUSION
    ANDREEN, M
    IRESTEDT, L
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1976, 98 (01): : 103 - 109
  • [8] ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO
  • [9] 2-2
  • [10] ANSFIELD FJ, 1964, JAMA-J AM MED ASSOC, V190, P686